التفاصيل البيبلوغرافية
العنوان: |
MO01.18 An indirect Comparison of Pembrolizumab+Chemo vs Ipilimumab+Nivolumab as First-Line Therapies in Patients with PD-L1 TPS≥1% Metastatic NSCLC |
المؤلفون: |
Thomas Burke, A. Frederickson, Bilal Piperdi, K. Vandormael, Ralph P. Insinga, C. Kalyvas, Balazs Halmos |
المصدر: |
Journal of Thoracic Oncology. 16:S23 |
بيانات النشر: |
Elsevier BV, 2021. |
سنة النشر: |
2021 |
مصطلحات موضوعية: |
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, biology, business.industry, First line, Ipilimumab, Pembrolizumab, Indirect comparison, Internal medicine, PD-L1, medicine, biology.protein, In patient, Nivolumab, business, medicine.drug |
تدمد: |
1556-0864 |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::b2f49b91edf4b74f9a619119d6cd2c41 https://doi.org/10.1016/j.jtho.2020.10.066 |
حقوق: |
OPEN |
رقم الأكسشن: |
edsair.doi...........b2f49b91edf4b74f9a619119d6cd2c41 |
قاعدة البيانات: |
OpenAIRE |